Skip to main content
Premium Trial:

Request an Annual Quote

Macrogen Signs License, Supply Agreement With Thermo Fisher for Capillary Electrophoresis Sequencing

NEW YORK – Macrogen said on Monday that it has signed a strategic license and supply agreement for capillary electrophoresis sequencing technology with Thermo Fisher Scientific.

The Korean company said it plans to use equipment and reagents from Thermo Fisher and to expand its overseas markets for CE sequencing services. As part of that, it has established laboratories in Spain and in Singapore and plans to open additional labs in Oceania and Europe.

"Macrogen is preparing to take the next big step in the market for [CE sequencing], which has been key to the company's initial growth and is growing rapidly thanks to the expansion of related applications," said Kap-Seok Yang, the company's CEO, in a statement. "Our agreement with global bio market leader Thermo Fisher Scientific will allow Macrogen to pursue global marketing that addresses the ongoing changes in the [CE sequencing] market."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more